Guizhou Xinbang Pharmaceutical Co Ltd (002390) — Financial Flexibility Index
Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥244.63 Million (operating CF CN¥234.19 Million minus capex CN¥10.43 Million) represents 0% of total liabilities (CN¥1.62 Billion). Check 002390 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guizhou Xinbang Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Guizhou Xinbang Pharmaceutical Co Ltd across 19 annual periods. See Guizhou Xinbang Pharmaceutical Co Ltd (002390) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Guizhou Xinbang Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see how much is Guizhou Xinbang Pharmaceutical Co Ltd worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.38x | CN¥759.84 Million | CN¥634.97 Million | CN¥2.01 Billion | ▼ -14.1% |
| 2023 | 0.44x | CN¥926.40 Million | CN¥790.62 Million | CN¥2.10 Billion | ▲ +60.3% |
| 2022 | 0.27x | CN¥749.58 Million | CN¥590.80 Million | CN¥2.73 Billion | ▲ +8.1% |
| 2021 | 0.25x | CN¥711.74 Million | CN¥457.97 Million | CN¥2.80 Billion | ▲ +29.8% |
| 2020 | 0.20x | CN¥880.20 Million | CN¥742.11 Million | CN¥4.49 Billion | ▼ -3.8% |
| 2019 | 0.20x | CN¥1.09 Billion | CN¥886.33 Million | CN¥5.37 Billion | ▲ +2475.8% |
| 2018 | 0.01x | CN¥44.96 Million | CN¥-218.56 Million | CN¥5.69 Billion | ▼ -93.5% |
| 2017 | 0.12x | CN¥636.77 Million | CN¥201.74 Million | CN¥5.20 Billion | ▲ +126.2% |
| 2016 | 0.05x | CN¥233.65 Million | CN¥-198.59 Million | CN¥4.31 Billion | ▼ -70.7% |
| 2015 | 0.19x | CN¥709.88 Million | CN¥217.40 Million | CN¥3.84 Billion | ▲ +509.0% |
| 2014 | 0.03x | CN¥84.04 Million | CN¥-198.60 Million | CN¥2.77 Billion | ▼ -41.6% |
| 2013 | 0.05x | CN¥23.46 Million | CN¥-21.34 Million | CN¥450.69 Million | ▼ -0.4% |
| 2012 | 0.05x | CN¥16.30 Million | CN¥-36.46 Million | CN¥311.99 Million | ▼ -75.6% |
| 2011 | 0.21x | CN¥56.61 Million | CN¥-39.87 Million | CN¥264.02 Million | ▼ -53.9% |
| 2010 | 0.47x | CN¥77.12 Million | CN¥2.50 Million | CN¥165.81 Million | ▲ +109.0% |
| 2009 | 0.22x | CN¥48.40 Million | CN¥41.75 Million | CN¥217.51 Million | ▲ +64.3% |
| 2008 | 0.14x | CN¥31.83 Million | CN¥24.86 Million | CN¥235.04 Million | ▼ -52.2% |
| 2007 | 0.28x | CN¥61.44 Million | CN¥32.49 Million | CN¥216.99 Million | ▲ +42.8% |
| 2006 | 0.20x | CN¥46.61 Million | CN¥7.35 Million | CN¥235.18 Million | — |